11.40 | 8.40 Panel Discussion: Conversations Between Pharma and Diagnostic Providers
Time: 11:40 am
day: Day One
• How is technology development in pharmaceutical teams affecting diagnostic partnerships and early
drug-Dx collaboration for effective biomarker strategy?
• Are there ways in which each team throughout the industry can work more effectively together?